Detalhe da pesquisa
1.
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38856236
2.
Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study.
Cancer
; 129(17): 2645-2654, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269074
3.
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor.
Bone Marrow Transplant
; 59(5): 597-603, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331980
4.
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
Blood Cancer J
; 14(1): 76, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697960
5.
Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study.
Bone Marrow Transplant
; 59(5): 604-614, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331982
6.
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.
Bone Marrow Transplant
; 59(2): 247-254, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040842
7.
PTCy versus CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin Lymphoma: a study of the LWP of the EBMT.
Blood Adv
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38810260
8.
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party.
Bone Marrow Transplant
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834689
9.
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant
; 58(9): 1033-1041, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386253
10.
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
Leukemia
; 37(7): 1511-1520, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157017
11.
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT.
Bone Marrow Transplant
; 57(12): 1788-1796, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114249
12.
Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.
Clin Cancer Res
; 28(19): 4258-4266, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670780
13.
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.
Blood Adv
; 6(3): 920-930, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861680
14.
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT.
Bone Marrow Transplant
; 56(11): 2742-2748, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247199
15.
Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT.
Bone Marrow Transplant
; 57(12): 1856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280759